Mar 9th, 2021
Clinical Interest Article
Mar 9th, 2021
Clinical Interest Article
Mar 9th, 2021
Clinical Interest Article
Dec 3rd, 2020
Clinical Interest Article
POPular TAVI Trial: Aspirin with or without Clopidogrel after transcatheter aortic-valve implantation
Published in the New England Journal of Medicine in October, the POPular TAVI trial randomized 665 patients under-going transcatheter aortic valve replace...
Dec 3rd, 2020
Clinical Interest Article
Trial shows addition of antiplatelet therapy not necessary after trans-catheter aortic valve replacement in patients already being treated with anticoagulation
In a study published in the New England Journal of Medicine in April of 2020, 313 patients who were already on oral anticoagulation being treated with a t...
Nov 17th, 2020
Clinical Interest Article
Boston Scientific suspends development of Lotus Edge TAVR platform
In a press release on November 17th, 2020, Boston Scientific announced that it will be discontinuing the Lotus trans-catheter aortic valve platform and wi...
Oct 16th, 2020
Clinical Interest Article
SOLVE-TAVI—coverage of TCT Connect 2020
A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve I...
Oct 15th, 2020
Clinical Interest Article
SCOPE 2—coverage of TCT Connect 2020
Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis
Jun 12th, 2020
Article
Most US Patients Have TAVR Options Nearby, but Proximity Isn’t Everything (TCTMD)
Race, sex, age, and socioeconomic status also influence TAVR access. For some, physician experience may trump convenience.